About
Greg Caswill trained as a chartered accountant and worked across sectors including restaurants and real estate investment before moving into pharma services, where he was Finance Director for PPS Europe (later sold to Paraxel). In 2002 he co-founded Envision Pharma Group, a provider of scientific and technology solutions to Medical Affairs divisions of pharmaceutical companies, and currently serves as its Executive Co-Chairman. He is also an active investor in a number of private businesses.
Invests in
Biotech
Investments
Board seats
Per the firm's website.
Colleagues at Halifax Group
Alex McNutt
Operating Executive at Halifax Group
Amit Swaroop
Principal at Halifax Group
Annette Harper
Executive Administrative Assistant at Halifax Group
Brendan Rennie
Senior Associate at Halifax Group
Charlie A. Alutto
Operating Executive at Halifax Group
Chris Cathcart
Managing Partner at Halifax Group
Clarisa Gonsalves
Executive Administrative Assistant at New Rhein Healthcare Investors, LLC
Dave Evans
Operating Executive at Halifax Group
Frequently asked questions
- Who is Greg Caswill?
- Greg Caswill trained as a chartered accountant and worked across sectors including restaurants and real estate investment before moving into pharma services, where he was Finance Director for PPS Europe (later sold to Paraxel). In 2002 he co-founded Envision Pharma Group, a provider of scientific and technology solutions to Medical Affairs divisions of pharmaceutical companies, and currently serves as its Executive Co-Chairman. He is also an active investor in a number of private businesses.
- Where does Greg Caswill work?
- Greg Caswill is Executive Co-Chairman of Envision Pharma Group at Halifax Group.
- What does Greg Caswill invest in?
- Greg Caswill invests in Biotech.
- What boards does Greg Caswill sit on?
- Greg Caswill holds tracked board seats at Envision Pharma Group.